Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-1994 | 04-1994 | 01-1994 | 10-1993 | 07-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 50 | 277 | 20 | 30 |
| Marketable Securities | 120 | 70 | 0 | 340 | 550 |
| Receivables | 20 | 10 | 36 | 60 | 110 |
| Inventories | 40 | 80 | 56 | 70 | 80 |
| Other current assets | 20 | -20 | 104 | 60 | 100 |
| TOTAL | $220 | $190 | $472 | $550 | $870 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1,363 | N/A | N/A |
| Other Non-Current Assets | 10 | 50 | 185 | 440 | 290 |
| TOTAL | $10 | $50 | $1,549 | $440 | $290 |
| Total Assets | $870 | $900 | $1,513 | $1,910 | $2,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 470 | 490 | 271 | 220 | 170 |
| Accrued Expenses | 70 | 90 | 96 | 80 | 70 |
| Other current liabilities | 30 | 8 | 125 | 70 | 140 |
| TOTAL | $630 | $670 | $552 | $450 | $400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 80 | 0 | 0 | 170 | 130 |
| TOTAL | $80 | $80 | $120 | $178 | $140 |
| Total Liabilities | $720 | $750 | $672 | $630 | $550 |
| Shareholders' Equity | |||||
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -5,670 | -5,670 | -4,898 | -4,460 | -4,180 |
| Other shareholders' equity | 623 | 623 | 646 | 643 | 643 |
| TOTAL | $140 | $140 | $842 | $1,270 | $1,560 |
| Total Liabilities And Equity | $860 | $890 | $1,513 | $1,900 | $2,110 |